Primary |
Product Used For Unknown Indication |
33.3% |
Hypertension |
17.9% |
Drug Use For Unknown Indication |
13.6% |
Atrial Fibrillation |
11.1% |
Blood Cholesterol |
3.8% |
Atrial Flutter |
2.2% |
Tachycardia |
2.2% |
Cardiac Failure Congestive |
1.6% |
Essential Hypertension |
1.6% |
Angina Pectoris |
1.4% |
Blood Pressure |
1.4% |
Convulsion |
1.4% |
Heart Rate Increased |
1.4% |
Myocardial Infarction |
1.4% |
Arrhythmia |
1.1% |
Blood Pressure Increased |
1.1% |
Heart Rate Abnormal |
1.1% |
Paronychia |
1.1% |
Angina Unstable |
0.8% |
Gastrooesophageal Reflux Disease |
0.8% |
|
Oedema Peripheral |
8.2% |
Vomiting |
8.2% |
Pharmaceutical Product Complaint |
6.6% |
Wheezing |
6.6% |
Blood Pressure Increased |
4.9% |
Drug Ineffective |
4.9% |
Overdose |
4.9% |
Palpitations |
4.9% |
Prostate Cancer |
4.9% |
Somnolence |
4.9% |
Swelling |
4.9% |
Upper Gastrointestinal Haemorrhage |
4.9% |
Urinary Tract Infection |
4.9% |
Weight Decreased |
4.9% |
Wrong Drug Administered |
4.9% |
Blood Pressure Decreased |
3.3% |
Condition Aggravated |
3.3% |
Drug Hypersensitivity |
3.3% |
Headache |
3.3% |
Hypertension |
3.3% |
|
Secondary |
Product Used For Unknown Indication |
35.4% |
Hypertension |
19.6% |
Atrial Fibrillation |
12.7% |
Drug Use For Unknown Indication |
10.1% |
Convulsion |
2.9% |
Blood Pressure |
2.0% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Anaesthesia |
1.6% |
Blood Pressure Abnormal |
1.6% |
Ingrowing Nail |
1.4% |
Type 2 Diabetes Mellitus |
1.3% |
Atrial Flutter |
1.1% |
Blood Triglycerides Increased |
1.1% |
Heart Rate Abnormal |
1.1% |
Heart Rate Increased |
1.1% |
Arthralgia |
1.0% |
Gastrooesophageal Reflux Disease |
1.0% |
Ill-defined Disorder |
1.0% |
Pneumonia |
1.0% |
Arrhythmia |
0.9% |
|
Weight Increased |
11.8% |
Wheezing |
7.9% |
Drug Hypersensitivity |
6.3% |
Malaise |
6.3% |
Oedema Peripheral |
5.5% |
Weight Decreased |
5.5% |
Blood Pressure Increased |
4.7% |
Drug Ineffective |
4.7% |
Fatigue |
4.7% |
Headache |
4.7% |
Overdose |
4.7% |
Vomiting |
4.7% |
Loss Of Consciousness |
3.9% |
Nausea |
3.9% |
Pneumonia |
3.9% |
Vision Blurred |
3.9% |
Dyspepsia |
3.1% |
Macular Degeneration |
3.1% |
Myocardial Infarction |
3.1% |
Rash |
3.1% |
|
Concomitant |
Product Used For Unknown Indication |
28.0% |
Drug Use For Unknown Indication |
20.7% |
Hypertension |
10.1% |
Atrial Fibrillation |
6.6% |
Asthma |
3.5% |
Pain |
3.2% |
Cardiac Disorder |
3.1% |
Chronic Obstructive Pulmonary Disease |
3.0% |
Diabetes Mellitus |
2.9% |
Depression |
2.4% |
Blood Cholesterol Increased |
2.3% |
Rheumatoid Arthritis |
2.0% |
Anxiety |
1.8% |
Menopause |
1.8% |
Osteoporosis |
1.7% |
Blood Pressure |
1.6% |
Type 2 Diabetes Mellitus |
1.5% |
Multiple Myeloma |
1.4% |
Prophylaxis |
1.3% |
Gastrooesophageal Reflux Disease |
1.3% |
|
Vomiting |
12.9% |
Weight Decreased |
8.4% |
Pain |
7.0% |
Weight Increased |
5.8% |
Urinary Tract Infection |
5.6% |
Myocardial Infarction |
5.3% |
Dyspnoea |
5.1% |
Drug Ineffective |
4.6% |
Nausea |
4.6% |
Unevaluable Event |
4.1% |
Death |
4.1% |
Pneumonia |
4.1% |
Tremor |
3.9% |
Urticaria |
3.7% |
Wheezing |
3.7% |
Sepsis |
3.6% |
Vision Blurred |
3.6% |
White Blood Cell Count Decreased |
3.4% |
Renal Failure |
3.4% |
Oedema Peripheral |
3.3% |
|
Interacting |
Hypertension |
16.3% |
Convulsion |
7.7% |
Gastrooesophageal Reflux Disease |
7.7% |
Anticoagulant Therapy |
6.7% |
Blood Pressure Abnormal |
6.7% |
Gout |
6.7% |
Drug Use For Unknown Indication |
5.8% |
Blood Pressure |
4.8% |
Ingrowing Nail |
4.8% |
Dental Care |
3.8% |
Dry Mouth |
3.8% |
Presbyoesophagus |
3.8% |
Tachycardia |
3.8% |
Flushing |
2.9% |
Heart Rate Abnormal |
2.9% |
Heart Rate Irregular |
2.9% |
Renal Disorder |
2.9% |
Blood Pressure Management |
1.9% |
Heart Rate Increased |
1.9% |
Urinary Tract Infection |
1.9% |
|
Tremor |
25.0% |
Heart Rate Increased |
7.1% |
Oesophageal Obstruction |
7.1% |
Pain |
7.1% |
Sepsis |
7.1% |
Dizziness |
3.6% |
Drug Interaction |
3.6% |
Drug Toxicity |
3.6% |
Headache |
3.6% |
Hypertension |
3.6% |
Hypotension |
3.6% |
Hypothyroidism |
3.6% |
Ill-defined Disorder |
3.6% |
Incorrect Drug Administration Duration |
3.6% |
Malaise |
3.6% |
Memory Impairment |
3.6% |
Palpitations |
3.6% |
Vomiting |
3.6% |
|